Boston Scientific (BSX) Reports In-Line Q4 EPS
Get Alerts BSX Hot Sheet
Price: $67.96 -0.23%
EPS Growth %: +8.5%
Financial Fact:
Cost of products sold: 594M
Today's EPS Names:
CPSS, HARL, MCET, More
EPS Growth %: +8.5%
Financial Fact:
Cost of products sold: 594M
Today's EPS Names:
CPSS, HARL, MCET, More
Join SI Premium – FREE
Boston Scientific (NYSE: BSX) reported Q4 EPS of $0.34, in-line with the analyst estimate of $0.34. Revenue for the quarter came in at $2.41 billion versus the consensus estimate of $2.38 billion.
For earnings history and earnings-related data on Boston Scientific (BSX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Rexford Industrial Realty (REXR) Reports In-Line Q1 EPS, provides guidance
- Equifax (EFX) shares tumble as Q2, full-year guidance falls short
- Kinder Morgan (KMI) Misses Q1 EPS by 1c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!